Position in SUPN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,403,988
+$3,171,148 QoQ
Shares Held
85,200
+73.9% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NATIXIS holds $42,325,153 across 10 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
281,576 | $33,285,098 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
85,200 | $4,403,988 | |
| 3 | VTRS |
Viatris Inc
|
134,531 | $1,817,513 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
34,000 | $768,400 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,175 | $696,751 | |
| 6 | EOLS |
Evolus, Inc.
|
141,437 | $581,306 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
13,589 | $409,300 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
2,647 | $348,715 |
All Filings in SUPN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,403,988 | 85,200 | Shares | Sole | 2026-05-14 | |
| 2020-12-31 | $1,232,840 | 49,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||